Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Issue Archive
Events
MM&M Awards 2012
Webcasts
MM&M Virtual Summit
Whitepapers
Directories
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
MMM
>
News
> Customized journal offers à la carte content
Customized journal offers à la carte content
Matthew Arnold
September 23, 2008
Print
Email
Reprint
Permissions
Text:
A
|
A
|
A
Sequence Medical's Journal of Medicine
More News
Sanofi braces for patent cliff impact
Unemployment picture brightens for US, but not for pharmas
Pfizer promotes Canada chief to lead US primary care marketing
White House sides with GSK sales reps
Pharma had third-most layoffs in Jan 2012
RELATED TOPICS
Pharmaceutical
Media
Marketing & Communications
Advertising
Professional
Trend
Medical Journal
Continuing Medical Education (CME)
Direct Marketing
Sales Force
Promotion
Company
Novartis
Sequence Medical is launching what it claims to be the first-ever individually customizable medical journal in the US.
The company's Journal of Medicine, launching in December, will be “the first and only peer-reviewed, multispecialty, indexed medical journal that is personalized to fit a physician's needs and then mailed to them in print form or available to them online,” the company said.
Sequence has assembled an editorial board for the venture and is soliciting original content for the magazine, a general version of which will go out monthly to all US medical libraries. But the magazine is also a platform for the firm's proprietary personalization system, by which physicians can order custom-built magazines – and advertisers can deliver customized promotions tailored to the individual physician, if they want.
“We've tried to set up personal marketing channels to each of our physician readers,” said founding partner Charles Benaiah, “so content can be specific to individual doctors.”
The publisher has signed up several “clients” (Benaiah shuns the term “advertiser,” since the journal also offers targeted editorial rep detail follow-up), including King Pharmaceutical, Boehringer-Ingelheim and Novartis.
As subscribers will be able to pick from dozens of topics or sub-specialties of interest, their choices will affect the frequency with which they get the magazine. Thus, said Benaiah, if a cardiologist chooses to receive only content related to hypertension and heart failure, she might receive the magazine quarterly, but should she choose all 15-20 topics within the specialty, she would get it monthly.
The Journal of Medicine will be the official journal of the Chronic Liver Disease Foundation, the Network for Oncology Communications and Research and the Coalition for Pain Education, and will cover 26 specialties.
Sequence also hopes to license its personalization system to other publishers.
Please enable JavaScript to view the
comments powered by Disqus.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MM&M Awards Photos
Most Popular
Most Emailed
Most Recent
Industry group releases digital best practices
Jobson Medical files for chapter 11 debt relief
AstraZeneca announces more layoffs, Q4 results
Komen, caught up in the culture wars, nurses damaged brand
Merck results buoyed by sales of Januvia franchise
Docs, patients and pharma
Allergan scrubs some doc-payment data, spares med-ed grants
Expanded use of Xgeva a longshot, analysts say
Pfizer promotes Canada chief to lead US primary care marketing
Amylin reports Q4 sales slump, touts Bydureon potential
Jobson Medical files for chapter 11 debt relief
Industry group releases digital best practices
Pfizer promotes Canada chief to lead US primary care marketing
Merck results buoyed by sales of Januvia franchise
Merck looks to wake up sleep aids category with suvorexant
White House sides with GSK sales reps
Merck, GSK shrug off rec to make HPV vaccine routine
Allergan scrubs some doc-payment data, spares med-ed grants
Sanofi braces for patent cliff impact
Expanded use of Xgeva a longshot, analysts say
Sanofi braces for patent cliff impact
Unemployment picture brightens for US, but not for pharmas
Pfizer promotes Canada chief to lead US primary care marketing
White House sides with GSK sales reps
Pharma had third-most layoffs in Jan 2012
Amylin reports Q4 sales slump, touts Bydureon potential
Digital think tank: Pharma Touchpoints
Case study—Nuvigil: Pay for Play
Gamification: Game On
Regulatory updates: First Glimmer of Guidance?
Popular Topics
Advertising
Approval
Brand
Corporate Reputation
DDMAC
Digital
Direct To Consumer (DTC)
DTC
Facebook
FDA
Financial
Generic
Guidance
Launch
Magazine
Major Statement
Manufacturing
Media
Medical Education
Off-label
Online
OPDP
Promotion
Social Media
Television